Optimizing Outcomes in Hypoparathyroidism: A New Era in Treatment Approaches - Episode 9
Safety and Titration Considerations and Quality of Life Impact of PTH-Based Therapy in Hypoparathyroidism
In ‘Safety and Titration Considerations and Quality of Life Impact of PTH-Based Therapy in Hypoparathyroidism,’ our panel delves into the potential titration challenges, safety considerations, and long-term monitoring of PTH-based therapy in patients with hypoparathyroidism. They also discuss the impact of PTH-based therapy on patient quality of life.
In ‘Safety and Titration Considerations and Quality of Life Impact of PTH-Based Therapy in Hypoparathyroidism,’ our panel delves into the potential titration challenges, safety considerations, and long-term monitoring of PTH-based therapy in patients with hypoparathyroidism. They also discuss the impact of PTH-based therapy on patient quality of life.
Led by the moderator, the expert endocrinologists examine the following critical questions:
- What has been your experience initiating palopegteriparatide in your practice?
- What challenges with titration have you encountered with your patients?
- What side effects have patients described, and what safety measures and long-term monitoring do you recommend?
- In what ways has palopegteriparatide impacted quality of life in your patients with chronic hypoparathyroidism?
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
Our next episode, ‘Multidisciplinary Approaches to Hypoparathyroidism Management,’ further explores hypoparathyroidism, highlighting the value of multidisciplinary collaboration, particularly in supporting patient adherence and engagement.
